David Granlund

David Granlund is an Associate Professor at Umeå School of Business, Economics and Statistics (USBE), Umeå University, specializing in health economics and industrial organization. His research explores pharmaceutical market competition, collusion detection, and public policy impacts. Contact: david.granlund@umu.se.

• Research Focus: Pharmaceutical price competition, parallel imports, therapeutic alternatives, antibiotic resistance, and collusion analysis.
• Current Projects: Leading studies on collusion mechanisms (Swedish Research Council), public sector efficiency (Jan Wallander/Tore Browaldhs Foundations), and pharmaceutical market collusion (Swedish Competition Authority).

Granlund's recent work investigates price discrimination in pharmaceutical supply chains, zero-price effects in drug choice, and collusion probability estimation. His empirical studies span 1303 Swedish pharmaceutical markets and cross-border healthcare economics.

• Scientific Awards & Grants: Multiple competitive grants, including SEK 4.07M (2025–2027) and SEK 2.79M (2025–2028).

Granlund is a member of the Economic Policy Network, contributing to cross-disciplinary research on healthcare reforms and market dynamics.